Eric Lefkofsky is the creator of Tempus. a company that is exploring ways to bring artificial intelligence into medical science. At the current moment, doctors usually prescribe an all-purpose solution for every subject. The side effects of this type of inexact therapy can often bring further suffering to the patient. The goal of Eric Lefkofsky’s Tempus is to use available scientific data to find an individual solution for each recipient.
Eric Lefkofsky became aware of a need for more specific research into an individual cancer patient’s condition about 3 years ago.
In the 3 years that Tempus has been working on these treatments, it has acquired over 700 employees and is worth over $3 billion. In 2017, Tempest obtained a licensing agreement with the American Society of Clinical Oncology. Data was hard to come by at first because many researchers were unsure about sharing any of it. At the present time, Tempus has data from over 1 million patients.
Eric Lefkofsky is a wealthy financier that has already launched 4 different companies. He began as a history major at the University of Michigan and made extra money selling rugs. He invested $100 million to found his latest venture in the Chicago-based Tempus, genomic testing, and data company.
Read: Eric Lefkofsky’s Company Leave (https://www.vox.com/2015/11/3/11620318/groupon-replaces-ceo-eric-lefkofsky-with-coo-rich-williams)
